Takeko Ishikawa
Itabashi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Real-world effectiveness and safety of lebrikizumab maintenance dosing every 4 weeks starting at week 4 after 2 loading doses in Japanese patients with atopic dermatitis.
Journal: JAAD international
Published: January 21, 2026
A 308-nm Excimer Lamp Ameliorates MC903-Induced Atopic Dermatitis With Reductions of Intraepidermal Nerve Fiber Density and Expression of Thymic Stromal Lymphopoietin.
Journal: The Journal of dermatology
Published: October 01, 2025
Introduction of Azygia hwangtsiyui (Trematoda: Azygidae) to Japan with its life cycle information.
Journal: Journal of helminthology
Published: May 02, 2025
Lifecycle of an introduced Dollfustrema (Bucephalidae) trematode in the Tone River system, Japan.
Journal: Journal of helminthology
Published: January 20, 2025
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis.
Journal: Experimental dermatology
Published: September 03, 2024
Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.
Journal: European journal of dermatology : EJD
Published: July 17, 2024
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
Journal: The Journal of dermatology
Published: February 29, 2024
Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world.
Journal: Experimental dermatology
Published: February 12, 2024
Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis.
Journal: Experimental dermatology
Published: November 24, 2023
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
Journal: The Journal of dermatology
Published: October 10, 2023
308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
Journal: The Journal of dermatology
Published: July 25, 2023
Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 17, 2023
Last Updated: 09/26/2026